PD-L1 Expression and Tumour Microenvironment Patterns in Resected Non-Small-Cell Lung Cancer

Background and Objectives: Although perioperative immunotherapy is implemented as a standard of care for resected non-small cell lung cancer (NSCLC), there is unmet need for predictive biomarkers as programmed death-ligand 1 (PD-L1) is not the perfect one. The functionality of tumour-infiltrating im...

Full description

Saved in:

Bibliographic Details
Published in:	Medicina (Kaunas, Lithuania) Vol. 60; no. 3; p. 482
Main Authors:	Gurevičienė, Giedrė, Matulionė, Jurgita, Poškienė, Lina, Miliauskas, Skaidrius, Žemaitis, Marius
Format:	Journal Article
Language:	English
Published:	Switzerland MDPI AG 01.03.2024 MDPI
Subjects:	B7-H1 Antigen - metabolism Biomarkers, Tumor - metabolism Cancer Cancer therapies Carcinoma, Non-Small-Cell Lung - metabolism Carcinoma, Non-Small-Cell Lung - surgery CD8-Positive T-Lymphocytes - metabolism Chemotherapy Chronic obstructive pulmonary disease FDA approval Health aspects Humans Immunotherapy Lung cancer Lung cancer, Non-small cell Lung diseases Lung Neoplasms - pathology Lymphocytes Lymphocytes, Tumor-Infiltrating - metabolism Medical equipment and supplies industry Medical prognosis Medical test kit industry Metastasis non-small cell lung cancer Prognosis programmed death-ligand 1 Radiation therapy Squamous cell carcinoma Statistical analysis T cells Tumor Microenvironment Tumors tumour microenvironment Lithuania United States United States > US non-small cell lung cancer programmed death-ligand 1 tumour microenvironment
ISSN:	1648-9144, 1010-660X, 1648-9144
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!